Abstract:Objective: Type 2 diabetes (T2D) is a complex disease caused by the combination of genetic factors and environmental factors. To date, although many loci, including genes and single nucleotide polymorphisms (SNPs), have been identified as risk variants of T2D, only approximately 10% of its heritability can be explained. In the current study, we proposed a data processing and analysis procedure to more accurately evaluate the association of the pathogenesis of T2D with copy number variations (CNVs). Methods: The data in our study came from the WTCCC (Wellcome Trust Case Control Consortium) genome-wide CNV database. Individual CNVs were identified by SW-ARRAY and CBS algorithms and genotyped with a global threshold method. Overlapped CNVs among all samples were split into smaller but more accurate CNV segments (CNVSegs) after the CNV call; then, LASSO-based logistic regression models with 10-fold cross-validations were performed 100 times to examine the association of CNVSegs with T2D. The AUC (area under the curve) in every model was summarized to preliminarily verify the classification ability of the models. Results: After quality control, 1,813 T2D cases and 2,777 controls were enrolled in the study. A total of 65,163 CNVs were identified, of which 25,512 were identified in the T2D group and 39,651 were identified in the healthy control group. A total of 22,279 CNVSegs were constructed after pre-processing the raw CNV data. By means of fitting 1,000 logistic regression models with the LASSO method, 26 CNVSegs were identified as T2D-associated CNVSegs according to pre-defined criteria (Frequency > 85% & Length > = 50 bp). Twenty-seven protein-coding genes were found to be overlapped with the CNVSegs, of which 11 were verified to be relevant to T2D, obesity or metabolic syndrome based on current published evidence. The average AUC of all models was 0.611 with the maximum being 0.683. Conclusions: Our study explored T2D-associated CNVSegs by LASSO-logistic regression models from the perspective of the whole genome for a more complete understanding of the genetic mechanisms of T2D. Further studies are necessary to verify the influence of the susceptibility loci on the pathogenesis or progression of T2D among different populations.

The construction of a local gene network of type 2 diabetes according to genome-wide association study

Identification of Key Gene Pathways and Coexpression Networks of Islets in Human Type 2 Diabetes.

Study of hub nodes of transcription factor-target gene regulatory network and immune mechanism for type 2 diabetes based on chip analysis of GEO database

Construction and Analysis of Functional Networks in the Gut Microbiome of Type 2 Diabetes Patients.

Causal network perturbation analysis identifies known and novel type-2 diabetes driver genes

Research on Potential Network Markers and Signaling Pathways in Type 2 Diabetes Based on Conditional Cell-Specific Network

Hub genes, key miRNAs and interaction analyses in type 2 diabetes mellitus: an integrative in silico approach

Key genes and co‐expression network analysis in the livers of type 2 diabetes patients

Identification of susceptible genes for complex chronic diseases based on disease risk functional SNPs and interaction networks

Meta-Analysis and Bioinformatics Detection of Susceptibility Genes in Diabetic Nephropathy

Pathogenic gene connections in type 2 diabetes and non-alcoholic fatty liver disease: a bioinformatics analysis and mouse model investigations experiments

Disease Gene Discovery of Single-Gene Disorders Based on Complex Network

Systematic Functional Characterization of Candidate Causal Genes for Type 2 Diabetes Risk Variants

EVALUATION OF THE ASSOCIATION BETWEEN THE PATHOGENESIS OF TYPE 2 DIABETES AND GENOME-WIDE COPY NUMBER VARIATIONS USING THE LASSO METHOD

Pathomechanisms of Type 2 Diabetes Genes

A Comparative Analysis of Genetic Diversity of Candidate Genes Associated with Type 2 Diabetes in Worldwide Populations.

A system biological approach to investigate the genetic profiling and comorbidities of type 2 diabetes

Systems Approach to Pathogenic Mechanism of Type 2 Diabetes and Drug Discovery Design Based on Deep Learning and Drug Design Specifications

Predicting of Disease Genes for Gestational Diabetes Mellitus Based on Network and Functional Consistency.

Identification of hub genes in the crosstalk between type 2 diabetic nephropathy and obesity according to bioinformatics analysis

Network Mendelian randomisation analysis deciphers protein pathways linking type 2 diabetes and gastrointestinal disease